Drug discovery > Basic Research Products & Reviews

Sino Biological provides an extensive range of premium products supporting organoid culture, differentiation, analysis, and identification.

Sino Biological can produce highly efficient antibodies in HEK293 and CHO cells in as fast as 2 weeks with 1,000+ Antibodies per batch.

Sino Biological recently launched a Research Highlights series to discuss the latest biomedical advancements and how our exclusive bioreagent products drive scientific breakthroughs. Our engaging and informative content bridges innovation and application, empowering you to make remarkable contributions to your field.

Sino Biological provides a wide range of influenza virus research reagents and technical services, supporting vaccine safety and immunogenicity assessment and vaccine protective efficacy evaluation.

Sino Biological has successfully developed a series of GMP-grade cytokines using the GMP-grade quality management system, which utilizes superior quality management and release testing criteria.

Sino Biological offers a wide range of products and services to provide customers with complete multispecific antibody development solutions covering various phases of the development process, such as antibody development and optimization, druggability assessment, animal model evaluation, and process development.

Sino Biological provides comprehensive solutions for CAR-T cell therapy companies from CAR development, T cell activation, lentivirus packaging, CAR-T cell expansion to CAR-T cell quality control, fully supporting CAR-T research.

Sino Biological has developed a series of high-quality research reagents for dominant SARS-CoV-2 mutants, including recombinant antigens, detection antibodies, ELISA kits, pseudovirus, cDNAs, peptide pools, and receptor ACE2. These variant reagents have actively supported the basic research of SARS-CoV-2 and the development of vaccines, therapeutic antibodies, and diagnostic reagents.

Owing to the importance of in vitro screening and target validation during the early stages of antibody discovery, Sino Biological has established in vitro activity assay platforms for streamlining antibody drug development projects.

Sino Biological provides comprehensive reagents and services for CAR-NK cell therapy development to support our customers from early target discovery to the preclinical phase of research and development.